Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-09-23, Stock:JNJ, The news for the past five days is as follows:
2019-09-16: NEWS1: Purdue Pharma Files For Bankruptcy: What You Need To Know.NEWS2: What's next for Purdue Pharma after filing for bankruptcy.NEWS3: S&P 500 buybacks decline significantly in Q2 2019; expenditures still remain higher than the pre-2018 levels.NEWS4: AstraZeneca's Farxiga Gets Fast Track Tag for Heart Failure.NEWS5: Amgen's Kyprolis Combo Improves PFS in Multiple Myeloma Study.NEWS6: CMR Surgical hits £1bn valuation as it rolls out robots for surgery.NEWS7: UPDATE 1-OxyContin maker Purdue Pharma files for bankruptcy protection.NEWS8: OxyContin maker Purdue Pharma files for bankruptcy protection.
2019-09-17: NEWS1: Johnson & Johnson (JNJ) Gains But Lags Market: What You Should Know.NEWS2: Should You Buy Vegan Stocks & ETF?.NEWS3: This new organic baby food will be on Whole Food shelves today.NEWS4: Novartis Announces New Data on Spondylitis Drug Cosentyx.NEWS5: Karyopharm Signs $150M Royalty Agreement to Support Xpovio.NEWS6: J&J Files sBLA for Tremfya With FDA for Psoriatic Arthritis.
2019-09-18: NEWS1: UPDATE 1-GSK's over-the-counter nicotine oral spray gets FDA panel backing.NEWS2: Johnson & Johnson to Host Investor Conference Call on Third Quarter Results.NEWS3: Establishment Labs Poised to Capitalize on Allergan Breast Implant Issues.NEWS4: Are You Looking for a High-Growth Dividend Stock? Johnson & Johnson (JNJ) Could Be a Great Choice.
2019-09-19: NEWS1: Johnson & Johnson Could Shrug Off Pressure In Third Quarter — Here's Why.NEWS2: Top Stock Reports for Johnson & Johnson, Boeing & Broadcom.NEWS3: J&J's Prostate Cancer Drug Gets FDA Nod for Expanded Use.NEWS4: Johnson & Johnson Stock Is Going to Rise Despite Opioid Lawsuits, Analyst Says.NEWS5: FDA Warns About Safety of Breast Implant: 3 Stocks at Risk.
2019-09-20: NEWS1: The Opioid Crisis Could Hurt Investors. Here’s How..NEWS2: Should Johnson & Johnson Investors Worry About Opioid Lawsuits?.NEWS3: How Opioid Lawsuits Could Hurt Investors.NEWS4: Gilead, AbbVie Are Innovative, but May Be Underappreciated.NEWS5: The New Capitalism Is Looking a Lot Like the Old Capitalism.NEWS6: The Zacks Analyst Blog Highlights: Johnson & Johnson, Boeing, Broadcom, Anthem and Allstate.NEWS7: Trovagene's Onvansertib Shows Response in Phase Ib AML Study.NEWS8: Walgreens Boots, Pfizer share gains contribute to Dow's nearly 75-point jump.NEWS9: Pharma Stock Roundup: FDA Approves Expanded Use of MRK/J&J's Drugs & Other Updates.NEWS10: Bull of the Day: Amgen (AMGN).

Answer: Rise